What is CORXEL Pharmaceuticals worth?
$474.9Mlast known valuation
CORXEL Pharmaceuticals last raised $287.0M in its Later Stage VC (Series D1) (Jan 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for CORXEL Pharmaceuticals
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series D1) | $287.0M | ▮ | ▮ |
How CORXEL Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CORXEL Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is CORXEL Pharmaceuticals worth?
- CORXEL Pharmaceuticals's last known valuation is $474.9M.
- How much has CORXEL Pharmaceuticals raised?
- CORXEL Pharmaceuticals has raised $451.8M in total funding across 1 recorded rounds.
- When did CORXEL Pharmaceuticals last raise?
- CORXEL Pharmaceuticals last raised in Jan 2026 (Later Stage VC (Series D1)), raising $287.0M.